Year All202620252024202320222021202020192018201720162015201420132012 June 10, 2026 Harrow Re-Launches VERKAZIA® (cyclosporine ophthalmic emulsion) 0.1% for Vernal Keratoconjunctivitis, Addressing Significant Unmet Need in Pediatric Eyecare May 27, 2026 Harrow to Present at William Blair’s 46th Annual Growth Stock Conference May 11, 2026 Harrow Announces First Quarter 2026 Financial Results April 27, 2026 Harrow To Report First Quarter 2026 Financial Results After Market Close on May 11, 2026 April 16, 2026 Harrow Announces the Issuance of J-Code for IOPIDINE® 1% March 24, 2026 Harrow Announces Pricing of $50.0 Million Offering of Senior Unsecured Notes Due 2030 March 24, 2026 Harrow Announces Add-On Offering of $50.0 Million of Senior Unsecured Notes to Support Growth March 18, 2026 Harrow Announces Three Abstracts Accepted for Presentation at ASCRS 2026 Annual Meeting